| L-T3 | L-triiodothyronine |
|---|---|
| L-T4 | L-thyroxine |
| L-tube | Levin tube |
| L-variant | a defective bacterial variant that can multiply on hypertonic medium |
| L-XRF | L x-ray fluorescence |
| L-[form] | a defective bacterial variant that can multiply on hypertonic medium |
| L-AP4 | L(+)-2-amino-4-phosphonobutanoate |
|---|---|
| L-AP4 | L(+)-2-amino-4-phosphonobutanoic acid |
| L-ARG | L-Arginine |
| L-ASA | lysine acetylsalicylate |
| L-ASP | L-Asparaginase |
| L-Asp | L-Aspartate |
| L-ASP | L-aspartic acid |
| L-BK | Lysyl-bradykinin |
| L-BSO | L-Buthionine sulfoximine |
| L-C | L-Carnitine |
| L-chain myeloma | bence Jones myeloma |
|---|---|
| l-cone | Long wavelength sensitive cone (red cone). (05 Mar 2000) |
| L-cysteine-cystine C-S lyase | <enzyme> C-des - cysteine desulfhydrase; a pyridoxal phosphate- containing enzyme from synechocystis involved information of fe-s cluster of ferredoxin; catalyses the breakdown of l-cysteine to yield sulfide, pyruvate and ammonia; increased activity with cystine, yielding cysteine persulfide as the primary product; mw about 43 kD Registry number: EC 4.4.1.- Synonym: c-des lyase (26 Jun 1999) |
| L-D body | The intracytoplasmic, nonflagellated leishmanial form of certain intracellular parasites, such as species of Leishmania or the intracellular form of Trypanosoma cruzi; originally used for Leishmania donovani parasites in infected spleen or liver cells in kala azar. Synonym: amastigote, L-D body. (05 Mar 2000) |
| l-dehydroascorbic acid | The reversibly oxidised form of ascorbic acid; it is antiscorbutic, but is converted in the body to 2,3-diketo-l-gulonic acid, which has no vitamin C activity. (05 Mar 2000) |
| l-dopa | <chemical> The naturally occurring form of dopa and the immediate precursor of dopamine. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonism and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Pharmacological action: antiparkinson agents, dopamine agents. (12 Dec 1998) |
| L-dopa peroxidase | <enzyme> Found in human erythrocytes associated with catalase Registry number: EC 1.11.- (26 Jun 1999) |
| L-erythro-3,5-diaminohexanoate dehydrogenase | <enzyme> Possible reaction mechanism given Registry number: EC 1.4.1.11 Synonym: 3,5-diaminohexanoate dehydrogenase (26 Jun 1999) |
| L-fucose permease | <chemical> Synonym: fucose permease (26 Jun 1999) |
| L-fuculokinase | <enzyme> Reaction: ATP + l-fuculose = ADP + l-fuculose 1-phosphate; from escherichia coli; has been sequenced Registry number: EC 2.7.1.51 Synonym: fuck gene product (26 Jun 1999) |
| L-galactitol-1-phosphate dehydrogenase | <enzyme> Nad-specific; forms d-tagatose-6-phosphate Registry number: EC 1.1.1.- Synonym: d-galactitol-6-phosphate dehydrogenase, galactitol-p-dhgase (26 Jun 1999) |
| L-galactonolactone oxidase | <enzyme> Flavin-containing enzyme from yeast which utilises oxygen as electron acceptor; forms ascorbic acid Registry number: EC 1.3.3.24 Synonym: galactono-gamma-lactone oxidase, l-galactono-1,4-lactone-oxygen 3-oxidoreductase (26 Jun 1999) |
| L-glyceraldehyde 3-phosphate-NADPH-dependent oxidoreductase | <enzyme> Converts l-glyceraldehyde 3-phosphate to sn-glycerol 3-phosphate; does not act on d-glyceraldehyde 3-phosphate or dihydroxyacetone phosphate Registry number: EC 1.1.1.- Synonym: l-gap oxidoreductase (26 Jun 1999) |
| l-glyceric aciduria | Excretion of l-glyceric acid in the urine; a primary metabolic error due to deficiency of d-glyceric dehydrogenase resulting in excretion of l-glyceric and oxalic acids, leading to the clinical syndrome of oxalosis with frequent formation of oxalate renal calculi. (05 Mar 2000) |
| L-glycol dehydrogenase | <enzyme> Catalyses NADPH linked reversible reduction of uncharged vicinal dicarbonyls and alpha-hydroxycarbonyls to l-(+)-glycols Registry number: EC 1.1.1.185 Synonym: l-(+)-glycol-NADP oxidoreductase, alpha-dicarbonyl reductase, l-(+)-alpha-hydroxycarbonyl-NADP oxidoreductase (26 Jun 1999) |
Synonyms : Cytochrome B2, Flavocytochrome B2, L-Lactate Cytochrome C Oxidoreductase, Lactate Dehydrogenase (Cytochrome), Lactate Flavocytochrome Reductase, Lactate-Ferricytochrome C Oxidoreductase, Cytochrome Reductase, Lactic, Flavocytochrome Reductase, Lactate
Synonyms : Lysine 2-Oxoglutarate 6-Aminotransferase, Lysine 6-Aminotransferase, Lysine epsilon-Transaminase, Lysine-6-Aminotransferase, Lysine-epsilon Aminotransferase, 2-Oxoglutarate 6-Aminotransferase, Lysine, 6-Aminotransferase, Lysine, 6-Transaminase, L-Lysine
Synonyms : CD62L Antigen, L Selectin, LAM-1, Leu-8 Antigen, Leukocyte Adhesion Molecule, LAM-1, Mel-14 Antigen, TQ1 Antigen, Antigen, CD62L, Antigen, Leu-8, Antigen, Mel-14, Antigen, TQ1, Leu 8 Antigen, Leukocyte Adhesion Molecule, LAM 1, Mel 14 Antigen, Selectin, L
Synonyms : L-Serine Ammonia-Lyase, Serine-Threonine Dehydratase, Ammonia-Lyase, L-Serine, Deaminase, Serine, Dehydratase, L-Serine, Dehydratase, Serine, Dehydratase, Serine-Threonine, L Serine Ammonia Lyase, L Serine Dehydratase, Serine Threonine Dehydratase
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
리브락인퓨전주 - 새창
|
신풍제약 |
A00302541 | L-Ornithine-L-Aspartate | 전문의약품 | 급여 | 분업예외의약품 |
|
엘칸주사1g - 새창
|
일동제약 |
A03401791 | L-carnitine | 전문의약품 | 급여 | 분업예외의약품 |
|
엘칸츄정1g - 새창
|
일동제약 |
A03402271 | L-carnitine | 일반의약품 | 급여 |
|
엘칸액 - 새창
|
일동제약 |
A03401801 | L-carnitine | 일반의약품 | 급여 |
|
엘칸정330mg - 새창
|
일동제약 |
A03402541 | L-carnitine | 일반의약품 | 급여 |
|
타치온주사 - 새창
|
동아제약 |
A01503011 | L-glutathione | 전문의약품 | 급여 |
|
타치온주200mg - 새창
|
동아제약 |
A01503891 | L-glutathione | 전문의약품 | 삭제 |
|
타치온정 - 새창
|
동아제약 |
A01502351 | L-glutathione | 일반의약품 | 급여 |
|
로이나제주 - 새창
|
Kyowa Hakko |
E02690181 | L-asparaginase | 전문의약품 | 급여 | 분업예외의약품 |
|
엘트릭스정 - 새창
|
삼남제약 |
A11800951 | Levothyroxine Sodium, Liothyronine Sodium | 전문의약품 | 급여 |
| L-dopa |
A chemical related to dopamine that is used in the treatment of Parkinson's disease.
출처: www.emc.maricopa.edu/faculty/farabee/BIOBK/BioBook...
|
|---|---|
| L-dopa |
This is a drug used to alleviate some of the symptoms of Parkinson's disease (see below), particularly trembling, rigidity, and slow movements; the drug is also called levodopa. Parkinson's disease results when the concentration of dopamine in the brain is depleted. L-dopa enters the brain through the bloodstream more easily than dopamine itself, and is there converted into dopamine. ...
출처: www.macalester.edu/~psych/whathap/UBNRP/nightmares...
|
| L-dopa |
also called dopaminergic agents; a dopamine-enhancing class of drugs most often used to treat Parkinson
출처: www.sleepcompliance.com/html/glossary.htm
|
| L-forms |
Spontaneous variants of bacteria that replicate as filterable spheres with defective or absent cell walls. They are filterable because of their flexibility rather than their size. Stable forms may grow for an indefinite time in a wall-le
출처:
|
| L-f. |
L-phase variant; see under variant.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
